TARRYTOWN, N.Y. — A natural children's cough syrup was recalled Tuesday due to health concerns and product stability, according to the U.S. Food and Drug Administration. Medtech Products Inc., a ...
An FDA advisory committee has voted against approving Merck & Co.’s gefapixant, a P2X3 receptor antagonist medicine designed to treat adults with chronic cough—a decision the Big Pharma disagrees with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback